ArticleCureus2024
Unilateral Proptosis as the Initial Manifestation of Acute Myeloid Leukemia in a Young Adult.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 22-year-old male presented with progressive unilateral proptosis, conjunctival chemosis, and vision loss in the right eye over the course of one month, without associated systemic symptoms such as fever, fatigue, or infections. Initial imaging, including CT and MRI, suggested benign orbital conditions like cavernous hemangioma or orbital pseudotumor. Despite the absence of systemic signs, hematological investigations revealed anemia, thrombocytopenia, and leukocytosis. A peripheral blood smear raised suspicion of a hematologic malignancy, which was confirmed by bone marrow biopsy, diagnosing acute myeloid leukemia (AML) with the t(8;21) translocation, a favorable cytogenetic subtype associated with AML with maturation. The patient was promptly started on induction chemotherapy with cytarabine and daunorubicin, resulting in a significant reduction of proptosis, improved extraocular movement, and partial restoration of vision. This case illustrates the unusual presentation of AML with initial ocular involvement, a rare but critical manifestation, and emphasizes the importance of considering hematological malignancies in young patients presenting with unexplained proptosis. Multidisciplinary collaboration led to a timely diagnosis and effective treatment. Early recognition and prompt initiation of chemotherapy are essential for both systemic remission and ocular recovery in such atypical cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.